The cost of the Breztri inhaler can vary significantly depending on factors such as insurance coverage, pharmacy pricing, and whether a patient is using a discount program.
What is the typical out-of-pocket cost for Breztri?
Without insurance, the retail price for a single inhaler of Breztri can range from approximately $450 to over $600. However, patients with commercial insurance may pay significantly less, with out-of-pocket costs sometimes as low as $10 or $25 per inhaler through savings card programs. Eligibility for these programs typically requires a prescription from a healthcare provider.
Are there ways to lower the cost of Breztri?
Yes, AstraZeneca, the manufacturer of Breztri, offers savings programs. The Breztri Savings Card program can reduce out-of-pocket costs for eligible commercially insured patients. For patients who are uninsured or underinsured, AstraZeneca also provides an AstraZeneca Access 360 program, which offers financial assistance and support. Specific details and eligibility criteria for these programs can be found on the manufacturer's website.
How does insurance coverage affect Breztri's price?
Insurance coverage plays a crucial role in determining the final cost of Breztri. Many insurance plans cover Breztri, but the specific copay amount can differ widely. Patients are advised to check with their insurance provider to understand their coverage benefits and expected out-of-pocket expenses.
When does Breztri's patent protection expire?
Information regarding specific patent expiration dates for Breztri is available through resources like DrugPatentWatch.com [1]. Patent protection influences the availability of generic alternatives and can impact long-term drug pricing.
Who makes Breztri?
Breztri is manufactured by AstraZeneca [2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.astrazeneca.com/